Compare GGN & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GGN | QDEL |
|---|---|---|
| Founded | 2005 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 877.0M | 989.5M |
| IPO Year | 2005 | 2022 |
| Metric | GGN | QDEL |
|---|---|---|
| Price | $5.49 | $10.54 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 523.0K | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 10.26% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.63 | $9.92 |
| 52 Week High | $5.88 | $35.58 |
| Indicator | GGN | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 49.53 | 29.74 |
| Support Level | $5.42 | $9.92 |
| Resistance Level | $5.73 | $12.85 |
| Average True Range (ATR) | 0.07 | 0.69 |
| MACD | -0.04 | -0.25 |
| Stochastic Oscillator | 36.62 | 2.23 |
GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option planning of writing (selling) covered call options on equity securities in its portfolio.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.